Meeting of the Tick-Borne Disease Working Group, 63122 [2020-22014]

Download as PDF 63122 Federal Register / Vol. 85, No. 194 / Tuesday, October 6, 2020 / Notices information as specified by the Secretary in order to receive a payment under section 6083. This form will allow FQHCs and RHCs to apply for such payments based on the average cost of training to obtain DATA 2000 waivers, as determined by the Secretary, for their physicians and practitioners to furnish opioid use disorder treatment services. The form will also provide HRSA with the requisite data to validate qualifying DATA 2000 waiver possessions for the purpose of ensuring accurate payments to FQHCs and RHCs. Likely Respondents: Only FQHCs and RHCs are eligible to apply. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Total responses Average burden per response (in hours) Total burden hours DATA 2000 Waiver Training Payment Program Application for Payment ...................................................................... 1,137 1 1,137 0.5 568.5 Total .............................................................................. 1,137 ........................ 1,137 ........................ 568.5 HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2020–22079 Filed 10–5–20; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Tick-Borne Disease Working Group Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As required by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the Tick-Borne Disease Working Group (TBDWG) will hold a virtual meeting. The meeting will be open to the public. For this meeting, the TBDWG will review chapters and the template for the 2020 report to the HHS Secretary and Congress. The 2020 report will address ongoing tick-borne disease research, including research related to SUMMARY: khammond on DSKJM1Z7X2PROD with NOTICES Number of responses per respondent VerDate Sep<11>2014 17:52 Oct 05, 2020 Jkt 253001 causes, prevention, treatment, surveillance, diagnosis, diagnostics, and interventions for individuals with tickborne diseases; advances made pursuant to such research; federal activities related to tick-borne diseases; and gaps in tick-borne disease research DATES: The meeting will be held online via webcast on October 27, 2020 from approximately 9:00 a.m. to 5:30 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the TBDWG web page at https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/ 2020-10-27/ when this information becomes available. FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services, Mary E. Switzer Building, 330 C Street SW, Suite L600, Washington, DC 20024. Email: tickbornedisease@ hhs.gov; Phone: 202–795–7608. SUPPLEMENTARY INFORMATION: The registration link will be posted on the website at https://www.hhs.gov/ash/ advisory-committees/tickbornedisease/ meetings/2020-10-27/ when it becomes available. After registering, you will receive an email confirmation with a personalized link to access the webcast on October 27, 2020 The public will have an opportunity to present their views to the TBDWG orally during the meeting’s public comment session or by submitting a written public comment. Comments PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 should be pertinent to the meeting discussion. Persons who wish to provide verbal or written public comment should review instructions at https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/ 2020-10-27/ and respond by midnight October 16, 2020 ET. Verbal comments will be limited to three minutes each to accommodate as many speakers as possible during the 30 minute session. Written public comments will be accessible to the public on the TBDWG web page prior to the meeting. Background and Authority: The TickBorne Disease Working Group was established on August 10, 2017, in accordance with Section 2062 of the 21st Century Cures Act, and the Federal Advisory Committee Act, 5 U.S.C. App., as amended, to provide expertise and review federal efforts related to all tickborne diseases, to help ensure interagency coordination and minimize overlap, and to examine research priorities. The TBDWG is required to submit a report to the HHS Secretary and Congress on their findings and any recommendations for the federal response to tick-borne disease every two years. Dated: September 25, 2020. James J. Berger, Designated Federal Officer, Tick-Borne Disease Working Group, Office of Infectious Disease and HIV/AIDS Policy. [FR Doc. 2020–22014 Filed 10–5–20; 8:45 am] BILLING CODE 4150–28–P E:\FR\FM\06OCN1.SGM 06OCN1

Agencies

[Federal Register Volume 85, Number 194 (Tuesday, October 6, 2020)]
[Notices]
[Page 63122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22014]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As required by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Tick-Borne Disease Working Group (TBDWG) will hold a virtual 
meeting. The meeting will be open to the public. For this meeting, the 
TBDWG will review chapters and the template for the 2020 report to the 
HHS Secretary and Congress. The 2020 report will address ongoing tick-
borne disease research, including research related to causes, 
prevention, treatment, surveillance, diagnosis, diagnostics, and 
interventions for individuals with tick-borne diseases; advances made 
pursuant to such research; federal activities related to tick-borne 
diseases; and gaps in tick-borne disease research

DATES: The meeting will be held online via webcast on October 27, 2020 
from approximately 9:00 a.m. to 5:30 p.m. ET (times are tentative and 
subject to change). The confirmed times and agenda items for the 
meeting will be posted on the TBDWG web page at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-10-27/ 
when this information becomes available.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS 
Policy, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, Mary E. Switzer Building, 330 C Street SW, 
Suite L600, Washington, DC 20024. Email: [email protected]; 
Phone: 202-795-7608.

SUPPLEMENTARY INFORMATION: The registration link will be posted on the 
website at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-10-27/ when it becomes 
available. After registering, you will receive an email confirmation 
with a personalized link to access the webcast on October 27, 2020
    The public will have an opportunity to present their views to the 
TBDWG orally during the meeting's public comment session or by 
submitting a written public comment. Comments should be pertinent to 
the meeting discussion. Persons who wish to provide verbal or written 
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2020-10-27/ and 
respond by midnight October 16, 2020 ET. Verbal comments will be 
limited to three minutes each to accommodate as many speakers as 
possible during the 30 minute session. Written public comments will be 
accessible to the public on the TBDWG web page prior to the meeting.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with Section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review federal 
efforts related to all tick-borne diseases, to help ensure interagency 
coordination and minimize overlap, and to examine research priorities. 
The TBDWG is required to submit a report to the HHS Secretary and 
Congress on their findings and any recommendations for the federal 
response to tick-borne disease every two years.

    Dated: September 25, 2020.
James J. Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Office of 
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2020-22014 Filed 10-5-20; 8:45 am]
BILLING CODE 4150-28-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.